Soley Therapeutics, a biotechnology company advancing novel therapeutics informed by integrated cell stress biology, today announced the presentation of new preclinical data at the American ...

Kazia Therapeutics Limited (Nasdaq: KZIA), a clinical-stage oncology company advancing therapies to reprogram cancer biology and overcome treatment resistance, announces the in-licensing of a first-in ...

The Undergraduate Cancer Biology Society (UCBS) was started in 2022 with inaugural President Sarah Elimam. Now our third year as a UAB Registered Student Organization, UCBS is excited to continue its ...

Byondis B.V., an independent biopharmaceutical company creating innovative targeted medicines for patients with cancer, will profile the Company’s first-in-class antifolate and phosphonate ...

WEST LAFAYETTE – Purdue University researcher Andrea Kasinski is developing a new class of cancer drugs using microRNAs, ...

Andrea Kasinski’s lab is developing a longer-lasting microRNA-34a designed to suppress multiple cancer-driving genes.

Better cancer care depends on better treatment options. That's why the Ontario Institute for Cancer Research (OICR) is supporting four Ontario-based research teams working to develop the next ...